Physician profile
Jayeshkumar K Patel
NPI 1316980527
$742.72
in general payments reported to CMS, 2019-2025
11 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.32 · 2021: $17.34 · 2022: $176 · 2023: $211 · 2024: $136 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $136.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $124.94 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.81 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $96.62 | 2022-2023 | Farxiga |
| Janssen Scientific Affairs, LLC | $92.07 | 2023 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.51 | 2023-2025 | Trulance, Xifaxan |
| Allergan, INC. | $40.73 | 2020-2021 | |
| Abbott Laboratories | $39.26 | 2025 | Freestyle Libre 3 |
| Currax Pharmaceuticals LLC | $15.93 | 2020 | |
| Novo Nordisk INC | $15.49 | 2023 | |
| Idorsia Pharmaceuticals US INC | $13.23 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayeshkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.